Skip to main content

Incidentally Detected Thyroid Follicular Adenoma on Myocardial Perfusion Scintigraphy with Tc-99m MIBI

  • Chapter
  • First Online:
Thyroid and Parathyroid Diseases

Abstract

Technetium-99m sestamibi (Tc-99m MIBI) is a routinely used radiopharmaceutical for myocardial perfusion scintigraphy (MPS). Here, we present a case of a 76-year-old woman with mild transient chest pain but normal laboratory examination results who underwent Tc-99m sestamibi (MIBI) myocardial perfusion imaging, and an abnormal focal radionuclide uptake in the left lobe of the thyroid gland was detected. After that, the patient underwent left hemithyroidectomy, and the result of the pathology came out as follicular adenoma. In this case, we wanted to discuss the significance of MIBI uptake in thyroid nodules and discuss the importance of evaluating raw data images for the detection of noncardiac pathologies in myocardial perfusion scintigraphy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. McBiles M, Albert T, Cote M. Sestamibi parathyroid imaging. Semin Nucl Med. 1995;25:221–34.

    Article  CAS  PubMed  Google Scholar 

  2. Coakley A, Kettle AG, Wells CP, O’Doherety MJ, Collins RE. Technetium-99m-sestamibi: a new agent for parathyroid imaging. Nucl Med Commun. 1989;10:791–4.

    Article  CAS  PubMed  Google Scholar 

  3. Bucerius J, Ahmadzadehfar H, Biersack H. 99mTc-Sestamibi clinical applications. Berlin: Springer; 2012.

    Book  Google Scholar 

  4. Giejda K, Piszczek S, Stembrowicz-Nowakowska Z, Saracyn M, Dziuk M, Kamiński G. Incidentally recognised thyroid focal uptake of 99mTc-sestamibi during stress myocardial perfusion scintigraphy. Endokrynol Pol. 2015;66:521–5. https://doi.org/10.5603/EP.2015.0064.

    Article  CAS  PubMed  Google Scholar 

  5. Földes I, Lévay A, Stotz G. Comparative scanning of thyroid nodules with technetium-99m pertechnetate and technetium-99m methoxyisobutylisonitrile. Eur J Nucl Med. 1993;20:330–3.

    Article  PubMed  Google Scholar 

  6. Williams KA, Hill KA, Sheridan CM. Noncardiac findings on dual-isotope myocardial perfusion SPECT. J Nucl Cardiol. 2003;10:395–402.

    Article  PubMed  Google Scholar 

  7. Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol. 2009;132:658–65. https://doi.org/10.1309/AJCPPHLWMI3JV4LA.

    Article  PubMed  Google Scholar 

  8. Trimboli P, Treglia G, Guidobaldi L, Saggiorato E, Nigri G, Crescenzi A, et al. Clinical characteristics as predictors of malignancy in patients with indeterminate thyroid cytology: a meta-analysis. Endocrine. 2014;46:52–9. https://doi.org/10.1007/s12020-013-0057-1.

    Article  CAS  PubMed  Google Scholar 

  9. Giovanella L, Suriano S, Maffioli M, Ceriani L, Spriano G. (99m)Tc-sestamibi scanning in thyroid nodules with nondiagnostic cytology. Head Neck. 2010;32:607–11. https://doi.org/10.1002/hed.21229.

    Article  PubMed  Google Scholar 

  10. Leidig-Bruckner G, Cichorowski G, Sattler P, Bruckner T, Sattler B. Evaluation of thyroid nodules—combined use of 99mTc-methylisobutylnitrile scintigraphy and aspiration cytology to assess risk of malignancy and stratify patients for surgical or nonsurgical therapy—a retrospective cohort study. Clin Endocrinol. 2012;76:749–58. https://doi.org/10.1111/j.1365-2265.2011.04292.x.

    Article  CAS  Google Scholar 

  11. Saggiorato E, Angusti T, Rosas R, Martinese M, Finessi M, Arecco F, et al. 99mTc-MIBI imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression. J Nucl Med. 2009;50:1785–93. https://doi.org/10.2967/jnumed.109.064980.

    Article  PubMed  Google Scholar 

  12. Treglia G, Caldarella C, Saggiorato E, Ceriani L, Orlandi F, Salvatori M, et al. Diagnostic performance of (99m)Tc-MIBI scan in predicting the malignancy of thyroid nodules: a meta-analysis. Endocrine. 2013;44:70–8. https://doi.org/10.1007/s12020-013-9932-z.

    Article  CAS  PubMed  Google Scholar 

  13. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133. https://doi.org/10.1089/thy.2015.0020.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mert, M., Sipahi, M. (2019). Incidentally Detected Thyroid Follicular Adenoma on Myocardial Perfusion Scintigraphy with Tc-99m MIBI. In: Özülker, T., Adaş, M., Günay, S. (eds) Thyroid and Parathyroid Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-78476-2_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-78476-2_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-78475-5

  • Online ISBN: 978-3-319-78476-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics